NEBIDO 1000MG 4ML SOLUTION FOR INJECTION

After the administration of radio-labelled testosterone, about 90% of the radioactivity appears in the urine as glucuronic and sulphuric acid conjugates and 6% appears in the faeces after undergoing enterohepatic circulation. Following intramuscular administration of this depot formulation the release rate is characterised by a half life of 90± 40 days. If severe upper abdominal complaints, liver enlargement or signs of intra-abdominal haemorrhage occur in men using Nebido, a liver tumour should be included in the differential-diagnostic considerations. Suspected anaphylactic reactions after nebido injection (a systemic and dangerous disease that occurs suddenly due to allergy and which are fatal if not urgently treated) have been reported.

What Nebido contains

Tell your doctor or the laboratory staff that you are using Testosterone Undecanoate. There is no data available on the use of Testosterone Undecanoate in males under 18years of age. The most common side effects are acne and pain where the injection is given. Like all medicines, this medicine can cause side effects, although not everybody gets them. This medicine contains 2000 mg benzyl benzoate in each 4 ml ampoule/vial which is equivalent to 500 mg/ml.

NEBIDO 1000 MG / 4ML SOLUTION FOR INJECTION – patient leaflet, side effects, dosage

Injections with this frequency are capable of maintaining sufficient testosterone levels and do not lead to accumulation. David, a 48-year-old accountant, had been struggling with erectile dysfunction for several years. This issue caused significant strain on his relationship with his partner. After a blood test revealed low testosterone levels, David’s doctor recommended TRT with NEBIDO injections every 12 weeks. Within a few months of treatment, David noticed a significant improvement in his erectile function and a renewed interest in intimacy.

• There are no studies undertaken to demonstrate the efficacy and safety of this medicinal product in patients with renal or hepatic impairment.
• • hypersensitivity to the active substance or to any of the excipients (listed in section 6.1).
• Each ml of solution contains 250 mg testosterone undecanoate equivalent to 157.9 mg testosterone.
• There is no data available on the use of Nebido in males under 18 years of age.
• There is limited experience on the safety and efficacy of the use of Nebido in patients over 65 years of age.
• The active form, testosterone, is formed by cleavage of the side chain.

Although it is unlikely that a tumor will emerge, this will be a health concern. In rare cases, there may be internal bleeding from these tumors that may endanger life. Therefore, if you suffer from severe abdominal pain, you should consult a doctor immediately.

Testosterone undecanoate is a prodrug of testosterone and is an androgen and anabolic–androgenic steroid (AAS). •    hypersensitivity to the active substance or to any of the excipients. Like all medicines, NEBIDO® may have side effects in people who are sensitive to the ingredients in its contents. Your doctor will determine the dosage https://www.toolguru.in/steroids-understanding-their-use-benefits-and-46/ of your medicine and apply it to you, depending on your disease.

NEBIDO (testosterone undecanoate) is a long-acting injectable form of testosterone used in testosterone replacement therapy (TRT) for men diagnosed with hypogonadism, a condition characterized by low testosterone production. Unlike other testosterone therapies that require frequent injections or daily applications, NEBIDO offers a convenient extended-release formulation with injections typically administered every weeks. The treatment did not exhibit any adverse side effects on the prostate gland, including prostate-specific antigen. Following intramuscular injection of testosterone undecanoate as an oily solution, the compound is gradually released from the depot and is almost completely cleaved by serum esterases into testosterone and undecanoic acid.